Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations

Molecular Cancer Research

Volumn 6, Issue 7, 2008, Pages 1146-1153

  Ma, Stephanie ^a   Kwok, Wah Chan ^a   Lee, Terence Kin Wah ^a   Kwan, Ho Tang ^a   Wo, Jana Yim Hung ^a   Zheng, Bo Jian ^a   Guan, Xin Yuan ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; GLYCOPROTEIN; ISOENZYME; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; ENZYMOLOGY; FLOW CYTOMETRY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTEOMICS; TUMOR CELL LINE; WESTERN BLOTTING;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; GLYCOPROTEINS; ISOENZYMES; LIVER NEOPLASMS; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEOMICS;

EID: 51649119918     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0035     Document Type: Article

References (25)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001;414:105-11.
2. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994;367:645-8.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;1000:3983-8.
4. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature 2004;432:396-401.
5. + cell population is enriched in tumor-initiating cells. Cancer Res 2007;67:6796-805.
6. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007;104:10158-63.
7. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006;44:240-51.
8. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006;351:820-4.
9. Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007;120:1436-42.
10. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-56.
11. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008;27:1749-58.
12. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858-63.
13. Hu L, Wen JM, Sham JS, et al. Establishment of cell lines from a primary hepatocellular carcinoma and its metastasis. Cancer Genet Cytogenet 2004;148:80-4.
14. Sophos NA, Vasilious V. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 2003;143:5-22.
15. Povsic TJ, Zavodni KL, Kelly FL, et al. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 2007;50:2243-8.
16. Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006;107:2162-9.
17. Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006;103:11707-12.
18. Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005;23:752-60.
19. Cheung AMS, Wan TSK, Leung JCK, et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 2007;21:1423-30.
20. Moreb JS, Zucali JR, Ostmark B, Benson NA. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. Cytometry B Clin Cytom 2007;72:281-9.
21. Sreerama L, Sladek NE. Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents. Adv Exp Med Biol 1997;414:81-94.
22. Jelski W, Zalewski B, Chrostek L, Szmitkowski M. Alcohol dehydrogenase (ADH)isoenzy mes and aldehyde dehydrogenase (ALDH)act ivity in the sera of patients with colorectal cancer. Clin Exp Med 2007;7:154-7.
23. Bar EE, Chaudhry A, Lin A, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007;25:2524-33.
24. Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol Vis 2005;11:729-37.
25. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67.